PharmaJet, Inc.

 Company Summary: Transaction Overview:
  • In June 2018, PharmaJet has entered into an exclusive global distribution agreement with Mundipharma.
  • The agreement involves a 5-year stock order commitment by Mundipharma worth over $50 million.
Significance of the Transaction:
  • The agreement grants PharmaJet access to over 120 countries and 6 continents through Mundipharma global distribution network.
  • The partnership serves as an inflection point in the Company’s global growth strategy.
Healthios Role:
  • Healthios served as strategic adviser to PharmaJet, organizing the partnership process, initiating introductions, coordinating due diligence, partner selection, term sheet development and transaction negotiation.
  • This transaction highlights Healthios global reach, our commitment to capital formation for emerging growth companies, our success in completing complex transactions, and our dedication to deep, long-term relationships.